iX Biopharma

Thread Rating:
  • 1 Vote(s) - 4 Average
  • 1
  • 2
  • 3
  • 4
  • 5
#1
Don't think i'll be subscribing this IPO..

iX Biopharma to launch IPO for Catalist listing

SINGAPORE: Pharmaceutical company iX Biopharma on Friday (Jul 10) announced plans for a listing on the Catalist board.

It is offering 65.5 million new shares at 46 cents each but only one million shares will be made available for the public. The remaining bulk of 64.5 million shares will be offered on placement basis.

iX Biopharma expects to raise S$27.6 million in net proceeds from the IPO.

The proposed listing comes amid a drought of IPOs on the Singapore Exchange (SGX) this year. There have been only three new Catalist listings on SGX in the first half of this year.

iX Biopharma specialises in the development and commercialisation of innovative therapies for pain management and male erectile dysfunction. It plans to use the bulk of its net proceeds to fund the clinical trials required for the development of its products.

iX Biopharma’s share offering will close on Jul 20 and its shares are expected to start trading on Jul 22.

- CNA/xq

http://www.channelnewsasia.com/news/sing...75522.html
Winston Churchill:-
“The inherent vice of capitalism is the unequal sharing of blessings; the inherent virtue of socialism is the equal sharing of miseries.”
"The farther backward you can look, the farther forward you are likely to see."
Reply
#2
This is the type of IPO that SGX will have going forward... those that even PE will deem risky...

Still in startup phase and I seriously don't know what sort of competitive advantages this upcoming IPO has...

Pls correct me if I m wrong...


(10-07-2015, 10:09 PM)Art or Science Wrote: Don't think i'll be subscribing this IPO..

iX Biopharma to launch IPO for Catalist listing

SINGAPORE: Pharmaceutical company iX Biopharma on Friday (Jul 10) announced plans for a listing on the Catalist board.

It is offering 65.5 million new shares at 46 cents each but only one million shares will be made available for the public. The remaining bulk of 64.5 million shares will be offered on placement basis.

iX Biopharma expects to raise S$27.6 million in net proceeds from the IPO.

The proposed listing comes amid a drought of IPOs on the Singapore Exchange (SGX) this year. There have been only three new Catalist listings on SGX in the first half of this year.

iX Biopharma specialises in the development and commercialisation of innovative therapies for pain management and male erectile dysfunction. It plans to use the bulk of its net proceeds to fund the clinical trials required for the development of its products.

iX Biopharma’s share offering will close on Jul 20 and its shares are expected to start trading on Jul 22.

- CNA/xq

http://www.channelnewsasia.com/news/sing...75522.html
Reply
#3
(11-07-2015, 08:23 PM)greengiraffe Wrote: This is the type of IPO that SGX will have going forward... those that even PE will deem risky...

Still in startup phase and I seriously don't know what sort of competitive advantages this upcoming IPO has...

Pls correct me if I m wrong...


(10-07-2015, 10:09 PM)Art or Science Wrote: Don't think i'll be subscribing this IPO..

iX Biopharma to launch IPO for Catalist listing

SINGAPORE: Pharmaceutical company iX Biopharma on Friday (Jul 10) announced plans for a listing on the Catalist board.

It is offering 65.5 million new shares at 46 cents each but only one million shares will be made available for the public. The remaining bulk of 64.5 million shares will be offered on placement basis.

iX Biopharma expects to raise S$27.6 million in net proceeds from the IPO.

The proposed listing comes amid a drought of IPOs on the Singapore Exchange (SGX) this year. There have been only three new Catalist listings on SGX in the first half of this year.

iX Biopharma specialises in the development and commercialisation of innovative therapies for pain management and male erectile dysfunction. It plans to use the bulk of its net proceeds to fund the clinical trials required for the development of its products.

iX Biopharma’s share offering will close on Jul 20 and its shares are expected to start trading on Jul 22.

- CNA/xq

http://www.channelnewsasia.com/news/sing...75522.html
If not for anything else, at least SGX's newIPO listing cater for both genders, SOG for the fairer sex & IX Biopharma for the guys Smile
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)